Biopharmaceutical Company Silo Pharma Launches Cryptocurrency Fund Management Strategy
ChainCatcher reports that biopharmaceutical company Silo Pharma (NASDAQ: SILO) has announced the launch of a cryptocurrency fund management strategy and appointed crypto infrastructure expert Corwin Yu as the first member of its Cryptocurrency Advisory Board. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Spot gold surpasses $4,290 per ounce.
The main contract of Nymex crude oil futures has surpassed $102 per barrel.
CrowdStrike CEO says slowing down AI development does not eliminate security risks
Crypto prices
More
